Molecular mechanisms of KMT2C alterations in gastrointestinal cancers: enhancer network destabilization, lineage plasticity, and clinical translation - Top-Institutions - MDSpire

Molecular mechanisms of KMT2C alterations in gastrointestinal cancers: enhancer network destabilization, lineage plasticity, and clinical translation

  • By

  • Xintao Zeng

  • Pei Yang

  • Tao Wang

  • Ruizi Shi

  • Chuan Qin

  • Lun Zhang

  • Ting Jiang

  • Xi Chen

  • Hua Luo

  • Jihong Wei

  • Haiyan Hu

  • Decai Wang

  • Jianjun Wang

  • May 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber/Harvard Cancer Center
    Dana-Farber/Harvard Cancer Center

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Gastrointestinal Cancer

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Gastrointestinal Cancer

Original Source(s)

Molecular mechanisms of KMT2C alterations in gastrointestinal cancers: enhancer network destabilization, lineage plasticity, and clinical translation

  • by Xintao Zeng, Pei Yang, Tao Wang, Ruizi Shi, Chuan Qin, Lun Zhang, Ting Jiang, Xi Chen, Hua Luo, Jihong Wei, Haiyan Hu, Decai Wang, Jianjun Wang

  • May 28, 2026

Related Content

Case Report and retrospective literature analysis of pediatric lower esophageal squamous cell carcinoma: focus on diagnostic challenges and therapeutic strategies

Influence of Helicobacter pylori Infection on Gut and Tumor Microbiomes and Its Relationship with Immunotherapy Outcomes in Gastrointestinal Malignancies

Gastrointestinal Cancers and Clinical Trials: What Patients Need to Know Earlier On

Breakthrough treatments for gastrointestinal cancers are being tested in clinical trials right now.

  • by

  • May 20, 2026

  • 9 min